Syngo.CT CaScoring

The syngo.CT CaScoring SOMARIS/8 VB50 is an image analysis software designed to assist physicians by quantifying coronary artery calcification from non-contrasted cardiac CT scans. It employs an enhanced algorithm to automatically calculate Agatston, mass, and volume scores and assign calcifications to specific coronary arteries, providing comprehensive data for cardiovascular risk assessment.

The syngo.CT CaScoring SOMARIS/8 VB50 is a post-processing image analysis software package designed to support physicians in evaluating and documenting calcified coronary lesions. Utilizing non-contrasted cardiac CT images, acquired through standard or low-dose spiral or sequential scanning protocols, the software enables users to interactively identify and mark these calcified lesions. A key capability of the system is the allocation of each lesion to one of several major coronary arteries: the right coronary artery (RCA), the left main coronary artery (LM), the left anterior descending artery (LAD), and the left circumflex artery (CX). Subsequently, syngo.CT CaScoring calculates critical metrics including the Agatston-equivalent score, mass score, and volume score for each specified coronary artery, as well as the corresponding total scores across all coronary arteries. The software also allows users to generate paper reports that consolidate calcium scoring data, user-documented images, cited literature, and other relevant information. This updated version, SOMARIS/8 VB50, introduces an enhanced algorithm for precomputing calcium scores and, significantly, extends its functionality to automatically label coronary calcifications according to the specific artery they most likely belong to, a new feature compared to its predicate. Non-clinical integration and functional testing confirmed that the device performs as intended. Performance evaluations, including bench tests and a reader study, were conducted for the retrained and extended algorithm. These studies demonstrated adequate and acceptable performance for the total Agatston-equivalent score and its classification into established risk categories. While the precise assignment of calcifications in complex bifurcation regions (between LM, LAD, and CX) was noted as challenging for both human readers and the algorithm, the overall performance in assigning calcifications to individual vessels was deemed adequate and acceptable, especially considering the primary clinical importance of total calcium scores. The software also incorporates user interface modifications.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. How does the syngo.CT CaScoring SOMARIS/8 VB50 algorithm's performance in assigning calcifications to specific coronary arteries (LM, LAD, CX, RCA) vary with different levels of calcification burden or in patients with anomalous coronary anatomy?; What were the specific pre-defined acceptability criteria and quantitative thresholds used in the bench test and reader study to evaluate the performance of the enhanced calcium scoring algorithm, particularly for the new coronary artery labeling feature?; Given the acknowledged difficulty in precise bifurcation lesion assignment, what is the quantitative error rate or inter-observer variability for this specific task when using the syngo.CT CaScoring SOMARIS/8 VB50 algorithm compared to manual expert consensus?; How does the 'Rapid Results Technology' mentioned for sending evaluation results to any generic DICOM viewer operate, and what are the typical data transfer times and compatibility considerations with various PACS environments?; What impact does the use of standard versus low-dose CT scanning protocols, and different CT scanner models, have on the accuracy and reproducibility of the Agatston, mass, and volume scores calculated by syngo.CT CaScoring SOMARIS/8 VB50?